Seminar SeriesRNA/DNA based analytics to guarantee product safety – challenges for N-of-1-treatments
Seminar SeriesFast Track to Final Drug Product: Understanding Costs, Challenges, and Timelines in Personalized Medicine Manufacturing
Seminar Series"Control of starting material quality for oligonucleotide therapeutics" and "To Synthesis and Beyond…Production of oligos for ‘N-of-1’ therapies"
